NASDAQ:BBNX Beta Bionics (BBNX) Stock Price, News & Analysis $14.67 +0.63 (+4.49%) As of 03/14/2025 04:00 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesInsider TradesSEC FilingsTrends About Beta Bionics Stock (NASDAQ:BBNX) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Beta Bionics alerts:Sign Up Key Stats Today's Range$14.08▼$15.7750-Day Range N/A52-Week Range$13.64▼$24.50Volume269,381 shsAverage Volume367,656 shsMarket Capitalization$628.74 millionP/E RatioN/ADividend YieldN/APrice Target$24.83Consensus RatingModerate Buy Company OverviewBeta Bionics, Inc. is a commercial-stage medical device company. It engages in the design, development, and commercialization of solutions for insulin-requiring people with diabetes. The company was founded by Edward R. Damiano on October 21, 2015 and is headquartered in Irvine, CA.Read More… Remove Ads Receive BBNX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Beta Bionics and its competitors with MarketBeat's FREE daily newsletter. Email Address BBNX Stock News HeadlinesBeta Bionics, Inc.'s Quiet Period To Expire on March 11th (NASDAQ:BBNX)March 6, 2025 | americanbankingnews.comBeta Bionics, Inc. (BBNX): Among Stocks With At Least $10 Million In Insider Spending RecentlyMarch 3, 2025 | insidermonkey.comYour Wealth is Under AttackHave you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's coming next. But here's the truth… This is just the beginning. Trump has made it clear his tariffs are coming, and that the market will get worse before it gets better. Luckily, our FREE Presidential Transition Guide details exactly what will happen in the next 100 days, and how to protect your hard-earned savings during these times. Don't wait for the next crash to wipe you out. Act now.March 16, 2025 | American Alternative (Ad)Beta Bionics to Announce Fourth Quarter and Full Year 2024 Financial Results on March 25, 2025February 27, 2025 | globenewswire.comBeta Bionics initiated with an Outperform at LeerinkFebruary 24, 2025 | markets.businessinsider.comBeta Bionics initiated with a Buy at BofAFebruary 24, 2025 | markets.businessinsider.comBuy Recommendation for Beta Bionics: Leveraging Untapped Market Opportunities and Innovative Product DifferentiationFebruary 24, 2025 | tipranks.comBeta Bionics initiated with a Buy at LadenburgFebruary 21, 2025 | markets.businessinsider.comSee More Headlines BBNX Stock Analysis - Frequently Asked Questions How have BBNX shares performed this year? Beta Bionics' stock was trading at $23.81 at the beginning of 2025. Since then, BBNX shares have decreased by 38.4% and is now trading at $14.67. View the best growth stocks for 2025 here. When did Beta Bionics IPO? Beta Bionics (BBNX) raised $204 million in an initial public offering on Thursday, January 30th 2025. The company issued 12,000,000 shares at a price of $17.00 per share. When did the company's quiet period expire? Beta Bionics' quiet period expired on Tuesday, March 11th. Beta Bionics had issued 12,000,000 shares in its IPO on January 30th. The total size of the offering was $204,000,000 based on an initial share price of $17.00. During the company's quiet period, insiders and underwriters that worked on the IPO were prevented from issuing any research reports or earnings estimates for the company because of SEC regulations. Now that the company's quiet period has ended, brokerages that served as underwriters are now able to initiate research on the company. How do I buy shares of Beta Bionics? Shares of BBNX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Today3/16/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & medical instruments Sub-IndustryMedical Equipment Current SymbolNASDAQ:BBNX Previous SymbolNASDAQ:BBNX CIK1674632 WebN/A Phone(949) 427-7785FaxN/AEmployees294Year FoundedN/APrice Target and Rating Average Stock Price Target$24.83 High Stock Price Target$30.00 Low Stock Price Target$20.00 Potential Upside/Downside+69.3%Consensus RatingModerate Buy Rating Score (0-4)2.78 Research Coverage9 Analysts Profitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$53.03 million Price / Sales11.86 Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares42,859,000Free FloatN/AMarket Cap$628.74 million OptionableN/A BetaN/A A Beginner's Guide to Investing in CannabisUnlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.Get This Free Report This page (NASDAQ:BBNX) was last updated on 3/16/2025 by MarketBeat.com Staff From Our PartnersElon Warns “America Is Broke”. Trump’s Plan Inside.Elon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredYour Wealth is Under AttackHave you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's...American Alternative | SponsoredNvidia’s CEO: “This Will Be a Multitrillion-Dollar Industry."If you missed out on the big boom in Nvidia… Listen up, because according to Nvidia's own CEO… Elon Musk...Brownstone Research | SponsoredDOGE could send 6 AI stocks through the roofStay alert for Elon Musk and the Department of Government Efficiency's next move … Expect an announcement f...Weiss Ratings | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | SponsoredOur #1 Defense Stock for MarchChina just deepened its military alliance with America's enemies in the Middle East... By conducting joint ...Behind the Markets | SponsoredIs 2025 really the best time to get rich in American history?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Beta Bionics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Beta Bionics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.